Joint Corp. Lowers 2026 Sales Forecast

The chiropractic franchisor cut its full-year system-wide sales outlook and expects fewer clinics by year-end 2026.

Updated on Nov. 8, 2026 in Healthcare

Live Poll

Have you skipped or delayed a routine checkup because of cost this year?

The Joint Corp. lowered its 2026 system-wide sales forecast to $508 million-$512 million, down from $519 million-$552 million. The company also expects comparable sales to decline 2.5%-3.5% this year and its clinic count to end about 50 below year-end 2025.

Why it matters

The revision signals continued pressure on patient spending and new patient volume at U.S. chiropractic clinics, which the company attributes to macroeconomic challenges. Because most of its clinics are franchised, the sales decline affects franchisees and the broader network more than the company's own reported revenue.

Q3 system-wide sales fell 3.1% to $123.3 million and comparable sales dropped 1.9%, with revenue up 1% to $13.6 million across 930 clinics. The 2026 adjusted EBITDA forecast of $12.5 million-$13.5 million was kept unchanged despite the lower sales outlook.

The players

The Joint Corp.

A Scottsdale, Arizona-based franchisor of chiropractic clinics that operates one of the largest networks of its kind in the United States.

Sanjiv Razdan

The chief executive officer of The Joint Corp. who led the company's leadership through its franchise-driven expansion.

The details

CEO Sanjiv Razdan attributed the revised outlook to macroeconomic challenges, lower average monthly patient spending and fewer new patients. Of the 930 clinics open at Sept. 30, 915 were franchised and 15 were company-owned or managed.

Sept. 30, 2025: Second-quarter comparable sales declined 2.8%.
Sept. 30, 2026: Quarter-end clinic count reached 930.
Nov. 5, 2026: Sales forecast was lowered to $508 million-$512 million.
End of 2026: Clinic count is expected to be about 50 below year-end 2025.

Market Landscape

The decline reflects consumers cutting back on discretionary out-of-pocket care as post-pandemic household budgets tighten. For a franchise network that depends on repeat patient visits, that contraction shows up directly in system-wide sales and clinic growth.

Patients may find fewer new clinic locations and less promotional pricing as franchise sales soften, though the company has not announced specific price changes. Prospective franchisees and investors face a weaker sales outlook for the network.

The takeaway

Falling patient spending and fewer new patients are the key signals to watch in the company's upcoming results. Readers comparing chiropractic options may want to weigh out-of-pocket costs carefully as demand softens.